All articles by Phillip Broadwith – Page 16
-
Business
Sanofi snaps up inhaled insulin licence
Deal gives Mannkind access to global manufacturing and distribution for recently-approved Afrezza
-
Business
Single shot antibiotic approved for skin infections
Third drug in three months approved under US antimicrobials incentive scheme
-
Business
Tetraethyl lead bribery case ends with four executives convicted
Three jailed over corruption to prolong sales of fuel additives in Iraq and Indonesia
-
Business
AstraZeneca stocks respiratory and cancer pipelines
A $2bn deal with Almirall and a raft of acquisitions and partnership deals bulk up two focus areas for the company
-
Business
Bruker winds down underperforming instrument lines
Stand-alone gas chromatographs and certain mass spectrometry products to be sold off
-
Business
Reckitt Benckiser to spin out US pharma arm
Declining heroin addiction treatment sales prompt divestment as company focuses on over-the-counter and consumer products
-
Business
Tata Chemicals to mothball Kenya plant
Closure blamed on high energy prices and will mean 200 jobs being cut
-
Business
Albemarle buys into lithium with Rockwood merger
$6.2 billion deal capitalises on battery market growth
-
Business
Co-operation keeps contracts coming
Clubbing together gives contract research organisations more power to win new business in an evolving market
-
Business
First of a new breed of anticancer antibodies approved in Japan
Ono claims Opdivo is the first anti-PD1 treatment in the world
-
Business
ADM to buy food ingredients specialist Wild Flavors
€2.3bn deal gets ADM into rapidly-growing area of naturally-sourced flavourings
-
Business
Ineos takes full control of Styrolution
€1.1bn deal sees BASF complete its planned exit from styrenics joint venture
-
Business
Genentech to buy breast cancer specialist Seragon
$1.7bn deal for hormone receptor-destroying drug pipeline
-
Business
PPG to buy Mexican paints firm Comex
$2.3bn deal expands US firm’s footprint in Central America
-
Business
Bayer to close polycarbonate plant and cut 90 jobs
Firm has already shut Chinese plant, and will also sell off businesses in Australia and New Zealand
-
Business
Inhaled insulin approved in US
European committee recommends approval for generic long-acting insulin
-
Business
Affymax folds after drug withdrawal
Unexplained allergic reactions to anaemia drug prompt firm to dissolve
-
Business
Biotech bounced back in 2013, says report
R&D investment increasing, but industry needs to use its cash more wisely
-
Business
Shire fends off AbbVie takeover bid
Board says deal undervalues the company and its growth potential
-
Business
Medtronic to buy Covidien for $43bn
Tax inversion deal continues consolidation theme among medical device makers